ESSA Pharma Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	33.96	57.34	138.08	56.6	53.6	15.03	3.96	8.99	1.58	3.7
Short-Term Investments	114.37	110.16	57.1	22.01	0	0	0	0	0	0
Cash & Cash Equivalents	148.33	167.5	195.19	78.61	53.6	15.03	3.96	8.99	1.58	3.7
Cash Growth	-11.44%	-14.19%	148.30%	46.67%	256.59%	279.83%	-55.96%	468.93%	-57.32%	-
Receivables	0.14	0.01	0.49	0.31	0.36	0.3	0.03	0.02	3.85	0.06
Other Current Assets	0.33	1.56	1.92	1.38	0.34	0.27	1.07	1.02	1.66	0.06
Total Current Assets	148.8	169.06	197.6	80.3	54.3	15.6	5.06	10.02	7.09	3.83
Property, Plant & Equipment	0.07	0.19	0.31	0.06	0	0	0.1	0.13	0.17	0.01
Goodwill and Intangibles	0	0	0	0	0	0.22	0.24	0.26	0.28	0.36
Other Long-Term Assets	0.26	0.26	0.26	0.22	0.27	0.2	0.21	0	0	0
Total Long-Term Assets	0.33	0.45	0.57	0.28	0.27	0.42	0.55	0.38	0.45	0.37
Total Assets	149.12	169.51	198.17	80.57	54.57	16.02	5.61	10.4	7.54	4.2
Accounts Payable	3.41	2.18	3.81	1.14	1.57	0.52	1.64	3.54	2.09	0.59
Current Debt	0.08	0.13	0.12	0.06	3.71	2.82	2.03	0	0	0
Other Current Liabilities	0	0	0	0	0.3	0	0.11	0.09	0	0
Total Current Liabilities	3.5	2.31	3.93	1.2	5.57	3.34	3.78	3.63	2.09	0.59
Long-Term Debt	0	0.08	0.21	0	0	3.5	5.93	0	0	0
Other Long-Term Liabilities	0	0	0.02	0.13	0.02	0.02	0.17	7.31	0.99	1.64
Total Long-Term Liabilities	0	0.08	0.23	0.13	0.02	3.52	6.1	7.31	0.99	1.64
Total Liabilities	3.5	2.39	4.16	1.33	5.59	6.87	9.88	10.94	3.08	2.23
Total Debt	0.08	0.21	0.33	0.06	3.71	6.32	7.96	0	0	0
Debt Growth	-61.79%	-36.47%	460.07%	-98.41%	-41.29%	-20.64%	-	-	-	-
Retained Earnings	-179.46	-152.88	-117.78	-80.97	-57.52	-44.37	-32.74	-28.24	-15.63	-5.95
Comprehensive Income	-2.12	-2.14	-2.08	-2.08	-2.08	-2.08	-2.08	-2.08	-1.74	-0.07
Shareholders' Equity	145.63	167.12	194.01	79.24	48.98	9.15	-4.27	-0.54	4.46	1.97
Net Cash / Debt	148.25	167.29	194.86	78.55	49.89	8.71	-4	8.99	1.58	3.7
Net Cash / Debt Growth	-11.38%	-14.15%	148.06%	57.45%	472.53%	-	-	468.93%	-57.32%	-
Net Cash Per Share	3.36	3.80	5.06	3.50	5.92	1.91	-2.75	6.68	1.72	4.72
Working Capital	145.3	166.75	193.67	79.09	48.72	12.25	1.28	6.39	5	3.24
Book Value Per Share	3.30	3.79	5.04	3.53	5.81	2.00	-2.94	-0.40	4.86	2.52

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).